Sonja Nelson is Chief Financial Officer of ImmunityBio, Inc.. Currently has a direct ownership of 15,410 shares of IBRX, which is worth approximately $81,364. The most recent transaction as insider was on Jan 12, 2021, when has been sold 16,364 shares (Common Stock) at a price of $15.0 per share, resulting in proceeds of $245,460. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.4K
0% 3M change
0% 12M change
Total Value Held $81,364

Sonja Nelson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 12 2021
SELL
Open market or private sale
$245,460 $15.0 p/Share
16,364 Reduced 51.5%
15,410 Common Stock
Jan 12 2021
BUY
Exercise of conversion of derivative security
$34,887 $3.07 p/Share
11,364 Added 26.34%
31,774 Common Stock
Jan 04 2021
SELL
Open market or private sale
$534,871 $13.62 p/Share
39,271 Reduced 65.8%
20,410 Common Stock
Jan 04 2021
BUY
Exercise of conversion of derivative security
$69,778 $3.07 p/Share
22,729 Added 27.58%
59,681 Common Stock

Also insider at

MOTS
Motus GI Holdings, Inc. Healthcare
AMAM
Ambrx Biopharma Inc. Healthcare
AMAM
Ambrx Biopharma, Inc.
SN

Sonja Nelson

Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on IBRX

Follow ImmunityBio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IBRX shares.

Notify only if

Insider Trading

Get notified when an Immunity Bio, Inc. insider buys or sells IBRX shares.

Notify only if

News

Receive news related to ImmunityBio, Inc.

Track Activities on IBRX